VeriSIM Life

📍 San Francisco, United States🗓 Founded 2017👥 27 employees💰 Last funded Jan 2022
Biotechnology Research🌐 verisimlife.com
Website LinkedIn
VeriSIM Life is building AI enabled biosimulation models. VeriSIM will tackle one of the biggest obstacles of drug development: animal testing for drug development. Animal testing is slow, ethically questionable, and doesn't act as much of a filter: 92% of all drug candidates that pass this preclinical testing never make it to market. VeriSIM's solution is to create disease-specific biosimulation models, which allow researchers at pharma companies to model in software how a drug will interact in animals. This will allow researchers to test 1000x more potential candidates in the same unit of time, ensuring that drugs that do make it to (human) clinical trials are far more likely to work, and therefore saving millions in annual costs.
4
Total investors
2
Early stage
2
Mid stage
0
Late stage
2017
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2019–2022 · investors recorded per year
2019220222
Recent (last 2y)Earlier
Frequently asked questions
Who invested in VeriSIM Life?
VeriSIM Life has 4 investors on record on gritt.io, including 2 early-stage backers, 2 mid-stage.
When did VeriSIM Life last raise funding?
The most recent investment in VeriSIM Life recorded on gritt.io was in January 2022.
When was VeriSIM Life founded?
VeriSIM Life was founded in 2017.
What industry is VeriSIM Life in?
VeriSIM Life operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is VeriSIM Life based?
VeriSIM Life is headquartered in San Francisco, United States.